health
EMA opens safety reviews of Deanxit and immunoglobulin medicines
The EMA’s PRAC has started reviewing reports of serious neurological and psychiatric effects linked to Deanxit, and increased allergic reactions associated with specific batches of human normal immunoglobulins. The reviews are investigations; the committee has not announced conclusions.